Upadacitinib Versus IL-17 Inhibitors in Patients With Psoriatic Arthritis

计划入组 70 人 · 首次发布于 2026 年 2 月 4 日

LTS of Siliq vs. Other Therapies Treating of Adults With Moderate-to-Severe Psoriasis

计划入组 3,500 人 · 首次发布于 2017 年 8 月 18 日

A Prospective Study to Assess the Efficacy of IL-17 Inhibitors on Subclinical Enthesitis in Patients With Moderate to Severe Psoriasis Based on Power Doppler (PD) Ultrasonography (PDUS)

计划入组 50 人 · 首次发布于 2025 年 5 月 23 日

DHODH/IL-17 Inhibitors (Incozen Therapeutics)

IL-17 inhibitors (oral, plaque psoriasis)

IL-17 NanoAb

Simcha Il 18, Inc.

United States

Alliance Foundation Trials, LLC

United States

吉林天衡英睿制药有限公司

QuantX Biosciences Raises $85M Series B to Advance Oral STAT6 and IL-17 Inhibitors

Emerging IL-17 Inhibitors Show Promise in Hidradenitis Suppurativa Treatment

IL-17 and IL-23 Inhibitors Show Promising Safety and Efficacy Profiles in Elderly Psoriasis Patients